Last week’s ISMPP-U webinar ‘Open Access and Medical Publishing’, developed by the Medical Publishing Insights & Practices (MPIP) initiative and Open Pharma and moderated by LaVerne Mooney (Pfizer) and Chris Winchester (Oxford PharmaGenesis), aimed to define the key elements of open access policies, to provide insight into the changing publishing environment and to understand the perspectives of non-commercial and commercial stakeholders on open access publishing.
Weekly digest: what’s happening in open science?
Featuring pharma taking the lead on sharing clinical trial results, where preprints end up, and the identity of peer reviewers.
Evidence Live – what is evidence-based medicine?
The problem of bias, both subconscious and conscious, in medical research was a consistent theme through many of the talks delivered at Evidence Live this year. As the first post in a series on the talks from Evidence Live, this article will give an overview of what evidence based medicine actually is. In his session, … Continue reading Evidence Live – what is evidence-based medicine?
Patients in publications – where are we now?
Patient engagement in medical research is a priority for the pharmaceutical industry; however, patient involvement in publications is rare.